Are agencies interested in adaptive licensing?

Slides:

Advertisements

Similar presentations

Siemens Healthcare Integrated Management System (Or the journey to it)

Advertisements

1 SLIM Social Learning for the Integrated Management and Sustainable Use of Water at Catchment Scale Barcelona Feb 2003 Kevin Collins Open University.

1 ITRC Mission ITRC is A state-led coalition working together with industry and stakeholders to achieve regulatory acceptance of environmental technologies.

University of Minho School of Engineering R&D Centre ALGORITMI / Department of Information Systems Uma Escola a Reinventar o Futuro – Semana da Escola.

‘Best Practice’ in Police Training? ‘Best Practice’ in Police Training? J. Francis-Smythe, University College Worcester INTRODUCTION.

Practitioners versus Academics Software Engineering Problems Academics Practitioners.

UNECE Working Party on Rail Transport Workshop on Passenger Accessibility of Heavy Rail Systems Geneva 19 November 2009 Policy and Legislative Context.

Walter G. Park Dept. of Economics American University Program on Information Justice and Intellectual Property Rights, American University, Washington.

Strategy and Regulatory Frameworks

Framework for Regulation May Outline of Presentation 1.Background – Initiation of the Framework – Purpose of the Framework Framework Review.

SCRLC Regulatory/Security Track. Topics Proposed SOW for Regulatory/Security Track Summary report : Annual Customs and Border Protection C-TPAT Seminar.

Developing a National Vision for Complementary and Alternative Medicine in Undergraduate Medical Education: a workshop report Marja Verhoef *, Michael.

Needs Assessment Presented By Ernest D. Pérez Capacity Building Assistance Trainer BORDER HEALTH FOUNDATION Tucson, Arizona CAPACITY BUILDING ASSISTANCE.

School Improvement Partnership Programme: Summary of interim findings March 2014.

Goals Achievement Partnership (GAP) Survey Why the GAP survey was administered.

United States-Canada Regulatory Cooperation Council TBWG Fall Plenary November,

Revised AQTF Standards for Registered Training Organisations Strengthening our commitment to quality - COAG February August 2006.

1 TECHNICAL ASSISTANCE NEEDED BY LDCs IN SERVICES NEGOTIATIONS Presented by: Teboho Tsekoa New Delhi, June 2006.

Page 1 Task 38 Australia New Zealand Participating Countries USA Canada Croatia Austria The Netherlands Denmark UK Sweden Norway Finland Ireland IEA Bioenergy.

Monitoring, reporting and evaluating climate change adaptation policies at national level in Europe - An overview of where we stand Stéphane Isoard, EEA.

The association between European Medicines Agency approval and Health Technology Assessment recommendations Iga Lipska 1,2, Anke Hövels 2, Neil McAuslane.

Regional Sediment Management Policy and Implementation Workshop April, 2009.

REEEP SOUTH ASIA Partners’ Meeting and Regional Preparatory Meeting John French REEEP Network Director International Secretariat Vienna, Austria. New Delhi,

BC SUPPORT Unit: Overview and update

Title of the Change Project

Title of presentation Copyright IDS and MeTA 2010

The most represented stakeholders within the NAPA process were governments, followed by research institutions, UN Agencies and local communities. Private.

Regulatory agency and pharmaceutical company responses mapped to the 10 Quality Decision Making Practices (n=76) Legend Best practice Needs improvement.

Report of Asia and Pacific Regional Workshop

International Energy Agency

Adverse Event Reporting

Challenges of European SMEs in ICT-Enabled Global Collaboration: Results from A European Survey Karsten Gareis, Matti Vartiainen, Katarina Stanoevska-Slabova.

Senior Vice President, The Commonwealth Fund

New economies: Scenarios with a likelihood >50% and impact

Median Box : 25th and 75th percentiles

KEY STAKEHOLDERS PERCEPTIONS OF HEOR USAGE IN LEBANON

Learning and teaching – lessons 3 School culture 4

Median submission gap, median approval time and percentage approved as expedited for new active substances (NASs) approved by six authorities:

Karen Hacker, MD MPH Director

4.2 CLIMATE SERVICES, ACTION AND RESILIENCE

Nat. Rev. Urol. doi: /nrurol

Survey of adults age 18 and older in eleven countries.

Regulatory Responses (n=11) Company Responses (n=20)

Type and impact of HTA-related scientific advice given during development The variability in HTA organisations and methodologies that are utilised in HTA.

“Metro Map” analysis of FDA facilitated regulatory pathways and their influence on median approval times The US Food and Drug Administration (FDA) has.

Building quality in HTA process and decision making

Common facilitating practices in facilitated regulatory pathways*

SRH & HIV Linkages Agenda

Rollout time breakdown: 24 common NASs in 7 jurisdictions

Regulatory Responses (n=11) Company Responses (n=20)

European Partnership for Supervisory Organisations in Health Services and Social Care (EPSO), Sofia, 12th October 2018 How does regulation impact on.

State of play of B2G eInvoicing in public procurement

The slide shows the seven key steps that make up a systematic approach to benefit-risk assessment for medicines. Source: The CIRS Benefit-Risk Research.

Key Stakeholders are aware of the Coalitions activities

We wanted to kick-off this meeting by reviewing:

Summary of the day (III)

Regional regulatory initiatives use different approaches

OECD good practices for setting up an RIA system Regional Capacity-Building Seminar on Regulatory Impact Assessment Istanbul, Turkey 20 November 2007.

Figure 26. Primary Care: Summary and Implications

Stanisław Mazur Cracow University of Economics

Assessment of quality decision making in regulatory agencies and pharmaceutical companies with QoDoS (Quality of Decision Making Orientation Scheme) Not.

The GATS Waiver – some key issues

Malcolm Johnson, Director, Telecommunication Standardization Bureau

7/30/2019 March 28, 2019 Modeling the impact of harmonized regulatory systems on lives saved in Eastern and South Africa 7th East African Health & Scientific.

Table 1. Most effective strategies to teach students to communicate the benefits and risks of medicines Strategy Considered most effective, %

By: Andi Indahwaty Sidin A Critical Review of The Role of Clinical Governance in Health Care and its Potential Application in Indonesia.

Definition of the problem and its key features

Assessment routes and timelines

Towards COP6: Possible elements of a Framework

An Agency Perspective on Plain Language Summaries of Publications

Presentation transcript:

Are agencies interested in adaptive licensing? New approaches to medicine development are being assessed that address both regulators’ and payers’ needs; these could potentially provide a streamlined, more cost- and time-effective approach to accelerate patient access to important new medicines. Despite the active interest and investigation into the development and use of these pathways there appear to be divergent perceptions regarding their definitions, key elements, benefits, barriers, implementations and complexities. No research has sought to develop a stakeholder perception profile of novel adaptive licensing (AL) pathways and currently available facilitated regulatory pathways (FRPs). To develop a baseline understanding of AL and FRP perceptions among key stakeholders in the medicine development, regulatory and access process a survey was conducted among key stakeholders: 252 individuals representing 90 organisations were invited to participate in the survey; 80 (32%) individual responses were returned; some responses reflected consolidated ideas for a single organization. Overall 50 (56%) of invited organisations responded. Respondents were from 14 countries, most commonly the USA (29), UK (14), Canada (7), Germany (5), Switzerland (5), Sweden (4), and Singapore (3). The figure above represents respondents’ answers to Question 1.5 - Rate how progressive and committed you believe each agency below to be with regard to helping to develop and seeking to assist in the successful implementation and use of novel AL pathways: Rating scale: 1= Agency is not interested to 5= Agency is highly committed. (N) = Number of responses From: Liberti L, Stolk P, McAuslane N, Somauroo A, Breckenridge A, Leufkens H. Adaptive licensing and facilitated regulatory pathways: A stakeholder perception survey. Presented at the annual Winter Meeting of the WHO Collaborating Centre for Pharmaceutical Policy and Regulation, Utrecht University, Utrecht, The Netherlands, 13 January 2015.